Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Leukemia Research
|
March 16, 2018
Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia
Eun-Ji Choi, Je-Hwan Lee, Jung-Hee Lee, et al.
Hemasphere
|
November 15, 2019
Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Steven E Coutre, Ian W Flinn, Sven de Vos, et al.
Blood
|
October 17, 2015
A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia
Susan M O'Brien, Nicole Lamanna, Thomas J Kipps, et al.
International Journal of Environmental Research and Public Health
|
July 2, 2021
Regional Features of Long-Term Exposure to PM<sub>2.5</sub> Air Quality over Asia under SSP Scenarios Based on CMIP6 Models
Sungbo Shim, Hyunmin Sung, Sanghoon Kwon, et al.
Blood Advances
|
January 4, 2018
Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma
Sven de Vos, Nina D Wagner-Johnston, Steven E Coutre, et al.
Psycho-Oncology
|
August 6, 2015
Patient reporting pain intensity immediately after surgery can be associated with underlying depression in women with breast cancer
Yoo Seok Kim, Hyuigyung Do, Jong Won Lee, et al.
Lancet (London, England)
|
September 5, 2020
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S Abramson, M Lia Palomba, Leo I Gordon, et al.
The Lancet. Oncology
|
February 1, 2017
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
Andrew D Zelenetz, Jacqueline C Barrientos, Jennifer R Brown, et al.
Lung
|
July 20, 2025
ICD-10 Diagnostic Coding Patterns and Clinical Correlates in Refractory Chronic Cough: Analysis from the Korean Chronic Cough Registry
Min-Hye Shin, Young-Jae Lee, Kyung Eun Park, et al.
ERJ Open Research
|
August 28, 2025
Treatable traits in chronic cough: a prospective evaluation for predicting cough persistence
Yeonhee Kim, Seung-Eun Lee, Eun-Jung Jo, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Leukemia Research
|
March 16, 2018
Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia
Eun-Ji Choi, Je-Hwan Lee, Jung-Hee Lee, et al.
Hemasphere
|
November 15, 2019
Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Steven E Coutre, Ian W Flinn, Sven de Vos, et al.
Blood
|
October 17, 2015
A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia
Susan M O'Brien, Nicole Lamanna, Thomas J Kipps, et al.
International Journal of Environmental Research and Public Health
|
July 2, 2021
Regional Features of Long-Term Exposure to PM<sub>2.5</sub> Air Quality over Asia under SSP Scenarios Based on CMIP6 Models
Sungbo Shim, Hyunmin Sung, Sanghoon Kwon, et al.
Blood Advances
|
January 4, 2018
Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma
Sven de Vos, Nina D Wagner-Johnston, Steven E Coutre, et al.
Psycho-Oncology
|
August 6, 2015
Patient reporting pain intensity immediately after surgery can be associated with underlying depression in women with breast cancer
Yoo Seok Kim, Hyuigyung Do, Jong Won Lee, et al.
Lancet (London, England)
|
September 5, 2020
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S Abramson, M Lia Palomba, Leo I Gordon, et al.
The Lancet. Oncology
|
February 1, 2017
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
Andrew D Zelenetz, Jacqueline C Barrientos, Jennifer R Brown, et al.
Lung
|
July 20, 2025
ICD-10 Diagnostic Coding Patterns and Clinical Correlates in Refractory Chronic Cough: Analysis from the Korean Chronic Cough Registry
Min-Hye Shin, Young-Jae Lee, Kyung Eun Park, et al.
ERJ Open Research
|
August 28, 2025
Treatable traits in chronic cough: a prospective evaluation for predicting cough persistence
Yeonhee Kim, Seung-Eun Lee, Eun-Jung Jo, et al.
Page
of 7